دورية أكاديمية

Safety and efficacy of endoscopic sleeve gastroplasty for obesity management in new bariatric endoscopy programs: a multicenter international study.

التفاصيل البيبلوغرافية
العنوان: Safety and efficacy of endoscopic sleeve gastroplasty for obesity management in new bariatric endoscopy programs: a multicenter international study.
المؤلفون: Sarkar, Avik, Tawadros, Augustine, Andalib, Iman, Shahid, Haroon M., Tyberg, Amy, Alkhiari, Resheed, Gaidhane, Monica, Kedia, Prashant, John, Elizabeth S., Bushe, Bryce, Martinez, Guadalupe Ma, Zamarripa, Felipe, Carames, Mine C., Carames, Juan C., Casarodriguez, Fernando, Bove, Vincenzo, Costamagna, Guido, Boskoski, Ivo, Kahaleh, Michel
المصدر: Therapeutic Advances in Gastrointestinal Endoscopy; 6/7/2022, p1-9, 9p
مصطلحات موضوعية: PREVENTION of obesity, RESEARCH, LENGTH of stay in hospitals, BARIATRIC surgery, SURGICAL complications, RETROSPECTIVE studies, TREATMENT effectiveness, WEIGHT loss, HOSPITAL care, ENDOSCOPIC gastrointestinal surgery, STOMACH surgery, BODY mass index, ADVERSE health care events, PATIENT safety
مصطلحات جغرافية: UNITED States, COLOMBIA, ITALY, MEXICO
مستخلص: Background: Endoscopic sleeve gastroplasty (ESG) is an incisionless procedure that reduces the size of the gastric cavity. In prior studies, it has been proven to be a safe and effective treatment for obesity. In this study, we performed a collaborative study to evaluate the effectiveness of ESG among new endobariatric programs. Methods: This was an international, multicenter study reviewing the outcomes of ESG in centers starting ESG programs. Total body weight loss, change of body mass index (BMI), excess body weight loss (EBWL), technical success, duration of hospitalization, and immediate and delayed adverse events and complications at 24 h, 1 week, and 1, 3, and 6 months post-procedure were evaluated. Results: A total of 91 patients (35 males) from six centers were included. The patients' mean BMI before the procedure was 38.7 kg/m2. BMI reduction at 3 months was 7.3 (p < 0.000), at 6 months 9.3 (p < 0.000), and at 12 months 8.6 (p < 0.000) from baseline. EBWL was 17.3% at 1 month (p < 0.000), 29.2% at 3 months (p < 0.000), and 35.6% at 6 months (p < 0.000). The mean procedure duration was 85.1 min. The mean length of hospital stay post-procedure was 27 h. Conclusion: ESG provides EBWL percentage sustained up to 12 months. These results are equivalent among the new ESG centers compared to previous studies by expert centers. Lay title: Endoscopic sleeve gastroplasty in new bariatric endoscopy programs: Plain Language Summary: This article is the result of a collaborative international study on new endoscopic programs offering endoscopic sleeve gastroplasty. The minimally invasiveness and increasing accessibility of this technique makes it very attractive for patients with obesity while being poor candidate for surgery or refusing surgery. This study will also provide valuable information regarding this rising technique of endobariatric treatment. [ABSTRACT FROM AUTHOR]
Copyright of Therapeutic Advances in Gastrointestinal Endoscopy is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:26317745
DOI:10.1177/26317745221093883